Brief: Casi Pharmaceuticals Announces Third Quarter 2022 Financial Results
14/11/2022 12:58
Nov 14 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS
* CASI PHARMACEUTICALS - REVENUE WAS $10.2 MILLION FOR THREE
MONTHS ENDED SEPTEMBER 30, 2022, COMPARED TO $8.1 MILLION FOR
THREE MONTHS ENDED SEPTEMBER 30, 2021
* CASI PHARMACEUTICALS INC QTRLY NET LOSS PER SHARE (BASIC
AND
DILUTED) $0.38
Source text for Eikon: ID:nPnb90yzca
Further company coverage: CASI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary